MiR-3677-3p, upregulated in HBV + HCC, drives sorafenib resistance by suppressing F-box only protein 31 (FBXO31)—a tumor-suppressive stem cell factor (SCF) ubiquitin ligase component. Here, FBXO31 is linked to hepatocellular carcinoma.